XML 14 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments
9 Months Ended
Sep. 30, 2013
Financial Instruments, Owned, at Fair Value [Abstract]  
Financial Instruments Disclosure [Text Block]
FINANCIAL INSTRUMENTS
Derivative Instruments
The Company is exposed to a variety of market risks, including the effects of changes in foreign currency exchange rates and interest rates. Market risk is the potential loss arising from adverse changes in market rates and prices. The Company’s risk management strategy includes the use of derivative instruments to reduce the effects on its operating results and cash flows from fluctuations caused by volatility in currency exchange rates.
The Company serves many of its U.S.-based clients using contact center capacity in the Philippines, India, Canada and Colombia. Although the contracts with these clients are typically priced in U.S. dollars, a substantial portion of the costs incurred to render services under these contracts are denominated in Philippine pesos (PHP), Indian rupees (INR), Canadian dollars (CAD) or Colombian pesos (COP), which represents a foreign exchange exposure. The Company also maintains a contract with a client priced in Australian dollars (AUD). The Company has hedged a portion of its exposure related to the anticipated cash flow requirements denominated in these foreign currencies by entering into forward exchange contracts and options with several financial institutions to acquire a total of PHP 29,802.0 at a fixed price of $696.8 at various dates through December 2016, INR 11,663.0 at a fixed price of $196.5 at various dates through December 2016, CAD 28.3 at a fixed price of $27.3 at various dates through December 2015 and COP 26,400.0 at a fixed price of $13.8 at various dates through December 2014, and to sell a total of AUD 33.6 at a fixed price of $34.2 at various dates through September 2014. These instruments mature within the next 39 months and had a notional value of $968.6 at September 30, 2013 and $590.4 at December 31, 2012. The derivative instruments discussed above are designated and effective as cash flow hedges. The following table reflects the fair values of these derivative instruments:
 
September 30, 2013
 
December 31, 2012
Forward exchange contracts and options designated as hedging instruments:
 
 
 
Included within other current assets
$
6.4

 
$
16.4

Included within other non-current assets
1.3

 
11.6

Included within other current liabilities
21.6

 
6.0

Included within other long-term liabilities
22.6

 
3.5


The Company recorded a deferred tax benefit of $14.2 and a deferred tax expense of $7.1 related to these derivatives at September 30, 2013 and December 31, 2012, respectively. A total of $22.4 of deferred losses and $11.4 of deferred gains, net of tax, related to these cash flow hedges at September 30, 2013 and December 31, 2012, respectively, were included in accumulated other comprehensive loss (OCL). As of September 30, 2013, deferred losses of $15.3 ($9.4 net of tax), on derivative instruments included in accumulated OCL are expected to be reclassified into earnings during the next twelve months. The following table provides the effect of these derivative instruments on the Company’s Consolidated Financial Statements for the three and nine months ended September 30, 2013 and 2012:

 
Gain (Loss)
Recognized in OCL
on Derivative
(Effective Portion)
 
Gain (Loss)
Reclassified from
Accumulated OCL
into Income
(Effective Portion)
 
Location of Gain (Loss) Reclassified
from Accumulated OCL into Income
(Effective Portion)
Three Months Ended September 30, 2013
 
 
 
 
 
Foreign exchange contracts
$
(13.5
)
 
$
(3.7
)
 
- Cost of providing services and products sold and Selling, general and administrative
Nine Months Ended September 30, 2013
 
 
 
 
 
Foreign exchange contracts
$
(53.0
)
 
$
2.0

 
- Cost of providing services and products sold and Selling, general and administrative
Three Months Ended September 30, 2012
 
 
 
 
 
Foreign exchange contracts
$
14.0

 
$
4.3

 
- Cost of providing services and products sold and Selling, general and administrative
Nine Months Ended September 30, 2012
 
 
 
 
 
Foreign exchange contracts
$
30.0

 
$
10.0

 
- Cost of providing services and products sold and Selling, general and administrative

The amount recognized related to the ineffective portion of the derivative instruments was not material for the nine months ended September 30, 2013.
The Company also enters into derivative instruments (forwards) to economically hedge the foreign currency impact of assets and liabilities denominated in nonfunctional currencies. The Company recorded a net gain of $4.5 and a net loss of $1.0 during the nine months ended September 30, 2013 and 2012, respectively, related to changes in fair value of these derivative instruments not designated as hedges. The gains and losses largely offset the currency gains and losses that resulted from changes in the assets and liabilities denominated in nonfunctional currencies. These gains and losses are classified within other income, net in the accompanying Consolidated Statements of Income. The fair value of these derivative instruments not designated as hedges at September 30, 2013 was $3.4.
The aggregate fair value of all derivative instruments in a liability position on September 30, 2013 is $44.2.
Short Term Investments
In December 2011, the Company made investments in certain securities, included within short-term investments in the Consolidated Balance Sheets, which are held in a grantor trust for the benefit of participants of the executive deferred compensation plan, which was frozen during the fourth quarter of 2011. This investment was made in securities reflecting the hypothetical investment balances of plan participants. As of September 30, 2013, the Company maintained investment securities with a fair value of $13.5 classified as trading securities. The investment securities include exchange-traded mutual funds, common stock of the Company and money market accounts. These securities are carried at fair value, with gains and losses, both realized and unrealized, reported in other income (expense), net in the Consolidated Statements of Income. The cost of securities sold is based upon the specific identification method. Interest and dividends on securities classified as trading are included in other income (expense), net.
Additionally, during 2013 and 2012 the Company made investments in time deposits with maturities greater than 90 days and less than 180 days, included within short-term investments in the Consolidated Balance Sheets. As of September 30, 2013, the Company maintained short-term time deposits with a fair value of $113.0.